Create Account | Sign In: Author or Forum

 
 
News  |  Journals  |  Conferences  |  Blogs  |  Articles  |  Forums  |  Twitter    
 

 Headlines:

 

Category: Cardiology | Family Medicine | Internal Medicine | Pharmacy | Journal

Back to Journal Articles

Long-Term NSAID Use Ups Risk of Atrial Fibrillation

Last Updated: September 14, 2010.

 

Other study finds adding clopidogrel to warfarin triples risk of bleeding in a-fib

Share |

Comments: (0)

Tell-a-Friend

 

  Related
 
Long-term use of nonsteroidal anti-inflammatory drugs is associated with an increased risk of chronic atrial fibrillation, according to research published in the Sept. 13 issue of the Archives of Internal Medicine. According to a second study published in the same issue, using combinations of anticoagulants -- as opposed to warfarin alone -- significantly raises the risk of bleeding events in patients with atrial fibrillation.

TUESDAY, Sept. 14 (HealthDay News) -- Long-term use of nonsteroidal anti-inflammatory drugs (NSAIDs) is associated with an increased risk of chronic atrial fibrillation (AF), according to research published in the Sept. 13 issue of the Archives of Internal Medicine. According to a second study published in the same issue, using combinations of anticoagulants -- as opposed to warfarin alone -- significantly raises the risk of bleeding events in patients with AF.

Raffaele De Caterina, M.D., of "G. d'Annunzio" University in Chieti, Italy, and colleagues conducted nested case-control studies which confirmed that the long-term use of corticosteroids is associated with an increased risk of chronic AF (rate ratio, 2.49), and discovered that long term use of NSAIDs also increased the risk (rate ratio, 1.44). The researchers could not prove a direct cause-effect relationship between NSAIDs and AF; since the use of anti-inflammatory drugs in general usually reflects underlying inflammatory disorders, inflammation itself may explain the link between the two.

Morten L. Hansen, M.D., of the Copenhagen University Hospital Gentofte in Denmark, and colleagues conducted a cohort study using nationwide registries to determine the risk of nonfatal and fatal bleeding when AF is treated with combinations of warfarin, aspirin, and clopidogrel as opposed to warfarin alone. The researchers found that dual treatment with warfarin and clopidogrel, as well as triple therapy with all three drugs, increased the risk of a bleeding event by more than three-fold.

"Combinations of warfarin, aspirin, and clopidogrel are frequently used in patients with AF. In real-life circumstances, combination therapy is associated with a much higher risk of severe bleeding than previously recognized," Hansen and colleagues conclude.

The original data collection for the ascertainment of cases of AF for the De Caterina study was performed with an unrestricted research grant from AstraZeneca. The Hansen study was supported by a grant from the Sanofi-Aventis group.

Abstract - De Caterina
Full Text (subscription or payment may be required)
Abstract - Hansen
Full Text (subscription or payment may be required)

Copyright © 2010 HealthDay. All rights reserved.


Previous: African-Americans May Be Reluctant Blood Donors Next: Availability Bias Has Role in Residents' Medical Errors

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)
 

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

  • Ask a Doctor Teams: Respond to patient questions and discuss challenging presentations with other members.

Doctors Lounge Membership Application

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2013
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.